Skip to main content

Advertisement

SpringerLink
Log in

Abnormal skin barrier in the etiopathogenesis of atopic dermatitis

  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

Prior studies revealed the key roles played by T-helper type 1 and type 2 (Th1/Th2) cell dysregulation, IgE production, mast cell hyperactivity, and dendritic cell signaling in the evolution of the chronic, pruritic, inflammatory dermatosis that characterizes atopic dermatitis (AD). Accordingly, current therapy has been largely directed toward ameliorating Th2-mediated inflammation and pruritus. This article reviews emerging evidence that the inflammation in AD results from inherited and acquired insults to the barrier, as well as the therapeutic implications of this new paradigm.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Sugarman JL, Fluhr JW, Fowler AJ, et al.: The objective severity assessment of atopic dermatitis score: an objective measure using permeability barrier function and stratum corneum hydration with computer-assisted estimates for extent of disease. Arch Dermatol 2003, 139:1417–1422.

    Article  PubMed  Google Scholar 

  2. Seidenari S, Giusti G: Objective assessment of the skin of children affected by atopic dermatitis: a study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin. Acta Derm Venereol 1995, 75:429–433.

    PubMed  CAS  Google Scholar 

  3. Proksch E, Folster-Holst R, Jensen JM: Skin barrier function, epidermal proliferation and differentiation in eczema. J Dermatol Sci 2006, 43:159–169.

    Article  PubMed  CAS  Google Scholar 

  4. Chamlin SL, Kao J, Frieden IJ, et al.: Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol 2002, 47:198–208.

    Article  PubMed  Google Scholar 

  5. Baker BS: The role of microorganisms in atopic dermatitis. Clin Exp Immunol 2006, 144:1–9.

    Article  PubMed  CAS  Google Scholar 

  6. Elias PM, Wood LC, Feingold KR: Epidermal pathogenesis of inflammatory dermatoses. Am J Contact Dermat 1999, 10:119–126.

    Article  PubMed  CAS  Google Scholar 

  7. Elias PM, Feingold KR: Does the tail wag the dog? Role of the barrier in the pathogenesis of inflammatory dermatoses and therapeutic implications. Arch Dermatol 2001, 137:1079–1081.

    PubMed  CAS  Google Scholar 

  8. Taieb A: Hypothesis: from epidermal barrier dysfunction to atopic disorders. Contact Dermatitis 1999, 41:177–180.

    Article  PubMed  CAS  Google Scholar 

  9. Grimalt R, Mengeaud V, Cambazard F: The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study. Dermatology 2007, 214:61–67.

    Article  PubMed  CAS  Google Scholar 

  10. Elias PM: Stratum corneum defensive functions: an integrated view. J Invest Dermatol 2005, 125:183–200.

    PubMed  CAS  Google Scholar 

  11. Elias PM: The skin barrier as an innate immune element. Semin Immunopathol 2007, 29:3–14.

    Article  PubMed  Google Scholar 

  12. Caubet C, Jonca N, Brattsand M, et al.: Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. J Invest Dermatol 2004, 122:1235–1244.

    Article  PubMed  CAS  Google Scholar 

  13. Brattsand M, Stefansson K, Lundh C, et al.: A proteolytic cascade of kallikreins in the stratum corneum. J Invest Dermatol 2005, 124:198–203.

    Article  PubMed  CAS  Google Scholar 

  14. Braff MH, Di Nardo A, Gallo RL: Keratinocytes store the antimicrobial peptide cathelicidin in lamellar bodies. J Invest Dermatol 2005, 124:394–400.

    Article  PubMed  CAS  Google Scholar 

  15. Oren A, Ganz T, Liu L, Meerloo T: In human epidermis, beta-defensin 2 is packaged in lamellar bodies. Exp Mol Pathol 2003, 74:180–182.

    Article  PubMed  CAS  Google Scholar 

  16. Walley AJ, Chavanas S, Moffatt MF, et al.: Gene polymorphism in Netherton and common atopic disease. Nat Genet 2001, 29:175–178.

    Article  PubMed  CAS  Google Scholar 

  17. Hachem JP, Wagberg F, Schmuth M, et al.: Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome. J Invest Dermatol 2006, 126:1609–1621.

    Article  PubMed  CAS  Google Scholar 

  18. Vasilopoulos Y, Cork MJ, Murphy R, et al.: Genetic association between an AACC insertion in the 3’UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis. J Invest Dermatol 2004, 123:62–66.

    Article  PubMed  CAS  Google Scholar 

  19. Hubiche T, Ged C, Benard A, et al.: Analysis of SPINK 5, KLK 7 and FLG genotypes in a french atopic dermatitis cohort. Acta Derm Venereol 2007, 87:499–505.

    Article  PubMed  CAS  Google Scholar 

  20. Folster-Holst R, Stoll M, Koch WA, et al.: Lack of association of SPINK5 polymorphisms with nonsyndromic atopic dermatitis in the population of Northern Germany. Br J Dermatol 2005, 152:1365–1367.

    Article  PubMed  CAS  Google Scholar 

  21. Weidinger S, Baurecht H, Wagenpfeil S, et al.: Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk. J Allergy Clin Immunol 2008, 122:560–568.e4.

    Article  PubMed  CAS  Google Scholar 

  22. Hachem JP, Crumrine D, Fluhr J, et al.: pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. J Invest Dermatol 2003, 121:345–353.

    Article  PubMed  CAS  Google Scholar 

  23. Di Nardo A, Wertz P, Giannetti A, Seidenari S: Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm Venereol 1998, 78:27–30.

    Article  PubMed  Google Scholar 

  24. Imokawa G, Abe A, Jin K, et al.: Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol 1991, 96:523–526.

    Article  PubMed  CAS  Google Scholar 

  25. Hachem JP, Houben E, Crumrine D, et al.: Serine protease signaling of epidermal permeability barrier homeostasis. J Invest Dermatol 2006, 126:2074–2086.

    Article  PubMed  CAS  Google Scholar 

  26. Sator PG, Schmidt JB, Honigsmann H: Comparison of epidermal hydration and skin surface lipids in healthy individuals and in patients with atopic dermatitis. J Am Acad Dermatol 2003, 48:352–358.

    Article  PubMed  Google Scholar 

  27. Irvine AD, McLean WH: Breaking the (un)sound barrier: filaggrin is a major gene for atopic dermatitis. J Invest Dermatol 2006, 126:1200–1202.

    Article  PubMed  CAS  Google Scholar 

  28. Hudson TJ: Skin barrier function and allergic risk. Nat Genet 2006, 38:399–400.

    Article  PubMed  CAS  Google Scholar 

  29. Fleckman P, Brumbaugh S: Absence of the granular layer and keratohyalin define a morphologically distinct subset of individuals with ichthyosis vulgaris. Exp Dermatol 2002, 11:327–336.

    Article  PubMed  Google Scholar 

  30. Howell MD, Kim BE, Gao P, et al.: Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 2007, 120:150–155.

    Article  PubMed  CAS  Google Scholar 

  31. Bieber T: Atopic dermatitis. N Engl J Med 2008, 358:1483–1494.

    Article  PubMed  CAS  Google Scholar 

  32. O’Regan GM, Sandilands A, McLean WH, Irvine AD: Filaggrin in atopic dermatitis. J Allergy Clin Immunol 2008, 122:689–693.

    Article  PubMed  Google Scholar 

  33. Sandilands A, Smith FJ, Irvine AD, McLean WH: Filaggrin’s fuller figure: a glimpse into the genetic architecture of atopic dermatitis. J Invest Dermatol 2007, 127:1282–1284.

    Article  PubMed  CAS  Google Scholar 

  34. Lynley AM, Dale BA: The characterization of human epidermal filaggrin. A histidine-rich, keratin filament-aggregating protein. Biochim Biophys Acta 1983, 744:28–35.

    PubMed  CAS  Google Scholar 

  35. Harding CR, Scott IR: Histidine-rich proteins (filaggrins): structural and functional heterogeneity during epidermal differentiation. J Mol Biol 1983, 170:651–673.

    Article  PubMed  CAS  Google Scholar 

  36. Fleckman P, Dale BA, Holbrook KA: Profilaggrin, a high-molecular-weight precursor of filaggrin in human epidermis and cultured keratinocytes. J Invest Dermatol 1985, 85:507–512.

    Article  PubMed  CAS  Google Scholar 

  37. Takahashi M, Tezuka T, Katunuma N: Filaggrin linker segment peptide and cystatin alpha are parts of a complex of the cornified envelope of epidermis. Arch Biochem Biophys 1996, 329:123–126.

    Article  PubMed  CAS  Google Scholar 

  38. Steinert PM, Marekov LN: The proteins elafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope. J Biol Chem 1995, 270:17702–17711.

    Article  PubMed  CAS  Google Scholar 

  39. Scott IR, Harding CR, Barrett JG: Histidine-rich protein of the keratohyalin granules. Source of the free amino acids, urocanic acid and pyrrolidone carboxylic acid in the stratum corneum. Biochim Biophys Acta 1982, 719:110–117.

    PubMed  CAS  Google Scholar 

  40. Rawlings AV, Scott IR, Harding CR, Bowser PA: Stratum corneum moisturization at the molecular level. J Invest Dermatol 1994, 103:731–741.

    Article  PubMed  CAS  Google Scholar 

  41. Abe T, Ohkido M, Yamamoto K: Studies on skin surface barrier functions: skin surface lipids and transepidermal water loss in atopic skin during childhood. J Dermatol 1978, 5:223–229.

    PubMed  CAS  Google Scholar 

  42. Werner Y, Lindberg M: Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis. Acta Derm Venereol 1985, 65:102–105.

    PubMed  CAS  Google Scholar 

  43. Fartasch M, Diepgen TL: The barrier function in atopic dry skin. Disturbance of membrane-coating granule exocytosis and formation of epidermal lipids? Acta Derm Venereol Suppl (Stockh) 1992, 176:26–31.

    CAS  Google Scholar 

  44. Scott IR, Harding CR: Filaggrin breakdown to water binding compounds during development of the rat stratum corneum is controlled by the water activity of the environment. Dev Biol 1986, 115:84–92.

    Article  PubMed  CAS  Google Scholar 

  45. Krien P, Kermici M: Evidence for the existence of a self-regulated enzymatic process within human stratum corneum-an unexpected role for urocanic acid. J Invest Dermatol 2000, 115:414–420.

    Article  PubMed  CAS  Google Scholar 

  46. Nylander-Lundqvist E, Back O, Egelrud T: IL-1 beta activation in human epidermis. J Immunol 1996, 157:1699–1704.

    PubMed  CAS  Google Scholar 

  47. Bisgaard H, Simpson A, Palmer CN, et al.: Gene-environment interaction in the onset of eczema in infancy: filaggrin loss-of-function mutations enhanced by neonatal cat exposure. PLoS Med 2008, 5:e131.

    Article  PubMed  Google Scholar 

  48. Jeong SK, Kim HJ, Youm JK, et al.: Mite and cockroach allergens activate protease-activated receptor 2 and delay epidermal permeability barrier recovery. J Invest Dermatol 2008, 128:1930–1939.

    Article  PubMed  CAS  Google Scholar 

  49. Novak N, Baurecht H, Schafer T, et al.: Loss-of-function mutations in the filaggrin gene and allergic contact sensitization to nickel. J Invest Dermatol 2008, 128:1430–1435.

    Article  PubMed  CAS  Google Scholar 

  50. Schlievert PM, Case LC, Strandberg KL, et al.: Superantigen profile of Staphylococcus aureus isolates from patients with steroid-resistant atopic dermatitis. Clin Infect Dis 2008, 46:1562–1567.

    Article  PubMed  Google Scholar 

  51. Aberg KM, Man MQ, Gallo RL, et al.: Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers. J Invest Dermatol 2008, 128:917–925.

    Article  PubMed  CAS  Google Scholar 

  52. Cork MJ, Robinson DA, Vasilopoulos Y, et al.: New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol 2006, 118:3–21; quiz 22–23.

    Article  PubMed  CAS  Google Scholar 

  53. Garg A, Chren MM, Sands LP, et al.: Psychological stress perturbs epidermal permeability barrier homeostasis: implications for the pathogenesis of stress-associated skin disorders. Arch Dermatol 2001, 137:53–59.

    PubMed  CAS  Google Scholar 

  54. Kurahashi R, Hatano Y, Katagiri K: IL-4 suppresses the recovery of cutaneous permeability barrier functions in vivo. J Invest Dermatol 2008, 128:1329–1331.

    Article  PubMed  CAS  Google Scholar 

  55. Altrichter S, Kriehuber E, Moser J, et al.: Serum IgE autoantibodies target keratinocytes in patients with atopic dermatitis. J Invest Dermatol 2008, 128:2232–2239.

    Article  PubMed  CAS  Google Scholar 

  56. Ong PY, Ohtake T, Brandt C, et al.: Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002, 347:1151–1160.

    Article  PubMed  CAS  Google Scholar 

  57. Miller SJ, Aly R, Shinefeld HR, Elias PM: In vitro and in vivo antistaphylococcal activity of human stratum corneum lipids. Arch Dermatol 1988, 124:209–215.

    Article  PubMed  CAS  Google Scholar 

  58. Bibel DJ, Aly R, Shinefield HR: Antimicrobial activity of sphingosines. J Invest Dermatol 1992, 98:269–273.

    Article  PubMed  CAS  Google Scholar 

  59. Nomura I, Goleva E, Howell MD, et al.: Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 2003, 171:3262–3269.

    PubMed  CAS  Google Scholar 

  60. Lomholt H, Andersen KE, Kilian M: Staphylococcus aureus clonal dynamics and virulence factors in children with atopic dermatitis. J Invest Dermatol 2005, 125:977–982.

    Article  PubMed  CAS  Google Scholar 

  61. Wehner J, Neuber K: Staphylococcus aureus enterotoxins induce histamine and leukotriene release in patients with atopic eczema. Br J Dermatol 2001, 145:302–305.

    Article  PubMed  CAS  Google Scholar 

  62. Leung DY, Harbeck R, Bina P, et al.: Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. J Clin Invest 1993, 92:1374–1380.

    Article  PubMed  CAS  Google Scholar 

  63. Sonkoly E, Muller A, Lauerma AI, et al.: IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 2006, 117:411–417.

    Article  PubMed  CAS  Google Scholar 

  64. Mazereeuw-Hautier J, Cope J, Ong C, et al.: Topical recombinant alpha1-antitrypsin: a potential treatment for Netherton syndrome? Arch Dermatol 2006, 142:396–398.

    Article  PubMed  Google Scholar 

  65. Sugarman J, Parish LJ: A topical lipid-based barrier repair formulation (EpiCeram cream) is high-effective monotherapy for moderate-to-severe pediatric atopic dermatitis. Presented at the IID Meeting 2008. Kyoto, Japan; May 14–17, 2008.

  66. Galli SJ, Tsai M, Piliponsky AM: The development of allergic inflammation. Nature 2008, 454:445–454.

    Article  PubMed  CAS  Google Scholar 

  67. De Benedetto A, Qualia CM, Baroody FM, Beck LA: Filaggrin expression in oral, nasal, and esophageal mucosa. J Invest Dermatol 2008, 128:1594–1597.

    Article  PubMed  Google Scholar 

  68. Elias PM, Hatano Y, Williams ML: Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. J Allergy Clin Immunol 2008, 121:1337–1343.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dermatology Service (190), VA Medical Center, 4150 Clement Street, San Francisco, CA, 94121, USA

    Peter M. Elias

Authors
  1. Peter M. Elias
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matthias Schmuth
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter M. Elias.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Elias, P.M., Schmuth, M. Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Allergy Asthma Rep 9, 265–272 (2009). https://doi.org/10.1007/s11882-009-0037-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11882-009-0037-y

Keywords

Search

Navigation